Tetragon Partners GP Ltd Quant / Systematic

Location: GRAND CAYMAN, E9

CIK: 0001515070 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 15, 2026

Total Value: $515M (100.0% shares, 0.0% debt)

Holdings (36)

New Positions (12)

Increased Positions (15)

PATH UIPATH INC 54.3%
Value $280M (-2.2%) Shares 25,207,628 (+44.5%) Est. Cost $14.24 Unrealized -5.3%
NKTR NEKTAR THERAPEUTICS 1.4%
Value $7.414M (+153.1%) Shares 103,037 (+48.7%) Est. Cost $53.46 Unrealized -9.6%
CLDX CELLDEX THERAPEUTICS INC NEW 1.9%
Value $9.907M (+49.6%) Shares 312,316 (+28.1%) Est. Cost $24.91 Unrealized +2.0%
KRYS KRYSTAL BIOTECH INC 1.0%
Value $5.081M (+74.4%) Shares 19,668 (+66.5%) Est. Cost $220.15 Unrealized +23.7%
WK WORKIVA INC 2.9%
Value $14.91M (+15.2%) Shares 250,000 (+66.7%) Est. Cost $71.19 Unrealized +5.1%
ALKS ALKERMES PLC 1.1%
Value $5.65M (+43.0%) Shares 159,791 (+13.2%) Est. Cost $29.40 Unrealized +10.0%
ARWR ARROWHEAD PHARMACEUTICALS IN 1.5%
Value $7.975M (+23.9%) Shares 127,198 (+31.2%) Est. Cost $35.60 Unrealized +84.6%
IMVT IMMUNOVANT INC 1.1%
Value $5.428M (+28.5%) Shares 218,507 (+31.5%) Est. Cost $21.03 Unrealized +24.8%
AGIO AGIOS PHARMACEUTICALS INC 1.1%
Value $5.577M (+26.4%) Shares 164,839 (+1.7%) Est. Cost $34.96 Unrealized -19.8%
AMLX AMYLYX PHARMACEUTICALS INC 0.9%
Value $4.418M (+34.1%) Shares 317,877 (+16.5%) Est. Cost $7.12 Unrealized +96.4%
SLN SILENCE THERAPEUTICS PLC 0.6%
Value $3.321M (+49.5%) Shares 630,161 (+72.5%) Est. Cost $5.74 Unrealized
PHVS PHARVARIS N V 1.2%
Value $6.261M (+15.9%) Shares 221,611 (+13.9%) Est. Cost $18.02 Unrealized +48.4%
HRMY HARMONY BIOSCIENCES HLDGS IN 0.6%
Value $3.343M (+7.9%) Shares 119,340 (+44.1%) Est. Cost $33.74 Unrealized +5.8%
MBX MBX BIOSCIENCES INC 0.8%
Value $4.343M (-3.9%) Shares 145,480 (+1.5%) Est. Cost $13.72 Unrealized +168.5%
DYN DYNE THERAPEUTICS INC 0.9%
Value $4.68M (-3.5%) Shares 258,132 (+4.1%) Est. Cost $12.14 Unrealized +41.0%

Unchanged Positions (4)